Michael joined Joy Ventures as a Research Analyst in 2023. Michael is an experienced researcher in the pharmaceutical and medical device field with a PhD in pharmaceutical sciences. He has a strong track record in identifying and evaluating new assets and partnership opportunities, building and implementing candidate evaluation strategies, as well as in end-to-end pre-clinical research strategic planning and execution.
Previously, Michael held a position at CLEXIO biosciences, where he was responsible for scientific assessment and sourcing of new assets and partnership opportunities in the CNS therapeutic area. Michael has also held positions as a pre-clinical project manager and a principal scientist in various organizations.
Michael is passionate about problem solving, scientific innovations and technological development opportunities.
Sources of joy: Petting cats and any quality time with my family.